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A mouse model displays host and bacterial strain differences
in Aerococcus urinae urinary tract infection
Nicole M. Gilbert1,*, Brian Choi2, Jingjie Du2, Christina Collins1, Amanda L. Lewis3, Catherine Putonti4,5 and
Alan J. Wolfe2
ABSTRACT
In recent years, the clinical significance of Aerococcus urinae has
been increasingly recognized. A. urinae has been implicated in
cases of urinary tract infection (UTI; acute cystitis and pyelonephritis)
in both male and female patients, ranging from children to older
adults. Aerococcus urinae can also be invasive, causing urosepsis,
endocarditis, and musculoskeletal infections. Mechanisms of
pathogenesis in A. urinae infections are poorly understood, largely
due to the lack of an animal model system. In response to this gap, we
developed a model of A. urinae urinary tract infection in mice. We
compared A. urinae UTI in female C3H/HeN and C57BL/6 mice and
compared four clinical isolates of A. urinae isolated from patients with
UTI, urgency urinary incontinence, and overactive bladder. Our data
demonstrate that host genetic background modulates A. urinae UTI.
Female C57BL/6 female mice rapidly cleared the infection. Female
C3H/HeNmice, which have inherent vesicoureteral reflux that flushes
urine from the bladder up into the kidneys, were susceptible to
prolonged bacteriuria. This result is consistent with the fact that
A. urinae infections most frequently occur in patients with underlying
urinary tract abnormalities or disorders that make them susceptible to
bacterial infection. Unlike uropathogens such as E. coli, which cause
infection and inflammation both of the bladder and kidneys in C3H/
HeN mice, A. urinae displayed tropism for the kidney, persisting in
kidney tissue even after clearance of bacteria from the bladder.
Aerococcus urinae strains from different genetic clades displayed
varying propensities to cause persistent kidney infection. Aerococcus
urinae infected kidneys displayed histological inflammation,
neutrophil recruitment and increased pro-inflammatory cytokines.
These results set the stage for future research that interrogates host-
pathogen interactions between A. urinae and the urinary tract.
KEY WORDS: Gram-positive, Inflammation, Kidney, Urinary tract
infection
INTRODUCTION
Aerococcus urinae is a Gram-positive, alpha-hemolytic bacterium
first identified as a cause of urinary tract infection (UTI)
(Aguirre and Collins, 1992). Since its initial description, the
reports of A. urinae infections have continued to rise. Awareness of
A. urinae as an emerging pathogen increased, especially following
the advent of MALDI-TOF mass spectrometry techniques that
allowed the organism to be discerned from staphylococci and
streptococci (Meletis et al., 2017; Cattoir et al., 2010). Aerococcus
urinae infects both males and females (Schuur et al., 1997),
especially those with local or systemic predisposing conditions,
such as elderly patients (Senneby et al., 2015) and those with
urologic conditions (Sierra-Hoffman et al., 2005), prostatic diseases
(Shelton-Dodge et al., 2011), urologic cancer (Higgins and Garg,
2017) or using urinary catheters (Sierra-Hoffman et al., 2005; Yu
et al., 2019). Aerococcus urinae infections have also been reported,
albeit rarely, in younger and apparently otherwise healthy patients
(Yabes et al., 2018; Sous et al., 2019) and pediatric cases are
beginning to emerge (Sous et al., 2019; Qureshi and Patel, 2018).
Aerococcus urinae has also been detected in patients without
clinically-defined UTI (Sierra-Hoffman et al., 2005), and was more
frequently detected in urine from postmenopausal women with
urgency urinary incontinence (UUI) compared to asymptomatic
controls (74% UUI, 28% non-UUI; P=0.002; n=118) (Pearce et al.,
2014). In addition to colonization and infection of the urinary tract,
A. urinae can cause invasive infections like bacteremia (Senneby
et al., 2016), urosepsis (Kim et al., 2017), endocarditis (Tai et al.,
2021; Ludhwani et al., 2020), aortitis (Chhibber et al., 2019), and
spondylodiscitis (Rougier et al., 2018; Lyagoubi et al., 2020), as
well as other musculoskeletal infections (Greco et al., 2018) and soft
tissue infections (Forsvall et al., 2019). The urinary tract is often
implicated as the source of these disseminated infections because
A. urinae is concurrently detected in urine (Senneby et al., 2016;
Lyagoubi et al., 2020).
The first complete genome sequence of A. urinaewas reported in
2016 for the urinary isolate CCUG 36881T from a case of UTI
(Carkaci et al., 2016). Whole genome sequencing and analysis of an
additional 40 A. urinae isolates from infection episodes of UTI,
bacteremia and infective endocarditis (IE) revealed substantial
genetic diversity with respect to genome size, the number and
identity of core genes and the presence of putative capsular
polysaccharide loci (Carkaci et al., 2017). There was also variability
among A. urinae genomes regarding the presence of homologs
of known virulence factors, including genes predicted to mediate
bacterial adherence and protect against phagocytosis. One hypothesis
to explain the wide range of clinical conditions associated with
A. urinae is that different strains contain the genetic makeup
necessary to cause particular phenotypes. However, in a previous
study, there was no apparent phylogenetic distinction between strains
isolated from urine or blood, or between those from patients with UTI
or bacteremia (Carkaci et al., 2017). We recently reported the genome
sequences of 24 strains obtained by transurethral catheterization of 21
women with and without lower urinary tract symptoms, including
those associated with UUI, stress urinary incontinence (SUI),Received 9 July 2021; Accepted 15 July 2021
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overactive bladder (OAB) andUTI.We found that their ability to self-
aggregate (i.e. flocculate) was related to phylogeny (Hilt et al., 2020).
However, whether or not there are differences between A. urinae
strains isolated from infection cases (e.g. UTI, bacteremia,
endocarditis) versus other conditions associated with lower urinary
tract symptoms (e.g. UUI, OAB) has not been examined at the level of
genomics or in experimental systems.
Since the clinical importance of A. urinae has been recognized
only relatively recently, we know little about how the bacterium
colonizes or infects the urinary tract and disseminates to cause
disease in other body sites. Likewise, we do not know what host
responses may mitigate or exacerbate A. urinae infection. To begin
to address these gaps in knowledge, we developed a model of A.
urinaeUTI in female mice. We compared A. urinae infection in two
different inbred mouse strains frequently used to study UTI, so that
we could compare our results to observations made for more well-
recognized uropathogens. We also compared the in vivo behavior of
four different A. urinae strains isolated from patients with UTI, UUI,
OAB, and a woman with no lower urinary tract symptoms.
RESULTS
Genomic comparison of A. urinae strains in relation to
clinical outcomes
To examine the potential relationship between phylogeny and
infection outcomes of patients, we assembled the raw reads and
compared the whole-genome average nucleotide identity (ANI) of
the 77 publicly available A. urinae genomes (Fig. 1). These A.
urinae strains comprised clinical isolates from cases of UTI,
bacteremia, IE, OAB, UUI, and SUI, as well as two isolates from
women with no urinary tract symptoms (asymptomatic controls).
While these strains clustered into five distinct clades based on their
ANI values, there was no apparent relationship between host disease
group (UTI, UUI, SUI, OAB, bacteremia, and IE) and clade
(ANOVA P=0.24 by clade; P=0.22 by symptom group). With the
exception of the controls, each disease status was represented in at
least three of the four clades that contained multiple isolates (B–E)
(Table S1). This new genome comparison supports the conclusion
that genome evolution alone is not a main determinant of clinical
outcomes of A. urinae infection.
Experimental A. urinae urinary tract infection depends on
mouse genetic background
Using the data in Fig. 1, we chose four A. urinae strains from our
collection to examine in the urinary tract of a mouse model. These
strains were from three different clades and were isolated from
patients with distinct clinical diagnoses: UMB80, isolated from a
postmenopausal woman with OAB (clade: Aerococcus urinae_B);
UMB3669, isolated from a postmenopausal woman with UUI
(clade: Aerococcus urinae_C); UMB5628, isolated from a woman
with a clinical UTI (clade: Aerococcus urinae_B), where A. urinae
was the predominant uropathogen identified by culture; and
UMB722, isolated from a control woman with no lower urinary
tract symptoms or other apparent urological conditions (clade:
Aerococcus urinae). These four strains have been characterized
extensively in vitro in terms of aggregative properties (Hilt et al.,
2020). When prepared in PBS as for mouse experiments, the strains
appeared similar to each other as determined by transmission
electron microscopy (TEM) analysis (Fig. S1).
We performed experiments in female C3H/HeN and C57BL/6
mouse strains, both of which have been used extensively in mouse
models of UTI with Gram-positive and Gram-negative uropathogens.
Of note, C3H/HeN mice have inherent vesicoureteral reflux (VUR),
whereby urine travels in a retrograde fashion from the bladder up
through the ureters and into the kidneys. In each experiment, the
bladder was inoculated transurethrally with 0.5–1×107 colony
forming units (CFU) A. urinae in 50 μl PBS. We first examined the
time course of A. urinae bacteriuria. In young C57BL/6 mice, all A.
urinae strains were cleared from the urine by 24 h post infection
(hpi; Fig. S2A,B, closed symbols). Rapid clearance by 24 hpi
occurred even if the inoculum dose was increased to 0.5–1×108
CFU (Fig. S2C). Since A. urinae often causes infection in older
individuals and was frequently detected in postmenopausal women
(Rasmussen, 2013; Price et al., 2020), we examined whether
bacteriuria would better persist in older C57BL/6 retired breeders
(Rb). While A. urinae titers 3 hpi were higher in Rb mice, nearly all
mice cleared bacteriuria by 24 hpi (Fig. S2A,B, open symbols).
These results demonstrate that wild-type female C57BL/6 mice do
not represent an optimal host for modeling A. urinae urinary tract
pathogenesis.
In contrast to results in C57BL/6 mice, all A. urinae strains tested
caused some level of acute bacteriuria 24 hpi in C3H/HeN mice
(Fig. 2A). This result is consistent with previous reports with other
Gram positive uropathogens (Kline et al., 2010, 2011). We
wondered whether the persistence of A. urinae in C3H/HeN mice
was simply a reflection of the presence of VUR in this mouse strain.
However, the urogenital bacteria Gardnerella vaginalis was cleared
from C3H/HeN mice by 12 hpi (Fig. S3). Therefore, persistent
bacteriuria is not a non-specific phenotype that results from the
inoculation of any urogenital bacterial species into the urinary tract
of C3H/HeN mice. Coupled with their widespread use for studying
other established uropathogens, these results support the utility of
C3H/HeN mice to study A. urinae UTI.
Aerococcus urinae strains cause different levels and
durations of bacteriuria
There was variation among strains in the level of acute bacteriuria
(Fig. 2A) and the rate of persistent bacteriuria out to 13 days post
infection (dpi); 71% (10/14) for UMB80, 89% (8/9) for UMB3669,
33% (3/9) for UMB722, and 20% (1/5) for UMB5628 (Fig. 2B–E).
It should be noted that, although the inoculum dosewas the same for
each strain as determined by CFU, the decreased ability of UMB722
to cause persistent infection is consistent with poorer growth in BHI
compared to the other strains (Fig. S4). However, UMB5628 grew
just as well, or better, than the other strains in BHI and nonetheless
was cleared from most mice. Although UMB3669 was best able to
cause persistent infection, this strain is hyper-aggregative in vitro,
which could have resulted in more total bacteria being inoculated
and also could confound CFU results in urine if similar aggregation
occurs in vivo. Therefore, for further characterization in the C3H/
HeN mouse model, we chose UMB80 because it caused persistent
bacteriuria, consistently grows well, and is not aggregative in BHI
media or when resuspended in PBS.
Aerococcus urinae bacteriuria is dose-dependent
We performed additional experiments with UMB80 to determine
the effect of modulating the inoculum dose on the time course of
bacteriuria. Bacteriuria was dose-dependent, with inocula of 107
CFU causing the highest levels of acute bacteriuria 3 and 24 hpi
(Fig. 3A,B) that persisted for at least 13 dpi in the majority of mice
(Fig. 2B). Mice inoculated with 106 CFU of UMB80 displayed a
variable pattern of bacteriuria (Fig. 3C). Mice inoculated with 105
CFU of UMB80 had low levels of bacteriuria acutely (Fig. 3A,B),
followed by proliferation between 3 hpi and 4 dpi, and then a steady
decline out to 13 dpi (Fig. 3D).
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Aerococcus urinae does not colonize or cause exfoliation
or inflammation in the bladders of C3H/HeN mice
Previous studies have shown that C3H/HeN mice with high levels of
bacteriuria after inoculation with UPEC have similarly high bacterial
loads in bladder and kidney tissues (Hannan et al., 2010). Thus, we
were surprised to find that the levels of UMB80 were quite low in the
bladders of mice 24 hpi, with many bladders harboring no detectable
CFU (Fig. 4A). Though these data visually suggested a dose-
dependent effect on bladder titers, there were no statistically significant
differences based on inoculum dose at this time point. At 13 dpi, 10 of
14 (71%) mice inoculated with 107 UMB80 had detectable bladder
CFU, and titers were significantly higher compared to those inoculated
with 106CFU, amongwhich only onemouse had bacteria remaining in
the bladder (Fig. 4A). Of note, when detected, bacterial loads of
UMB80 in bladder tissue were substantially lower than what has been
reported for UPEC (Hannan et al., 2010).
Clearance of UMB80 from the bladder suggested an inability of
the organism to effectively adhere to the urothelium. Consistent with
Fig. 1. Whole genome ANI analysis of clinical A.
urinae strains. The 77 clinical A. urinae strains cluster
into five major groups based on a 95% ANI threshold.
The dashed line indicates this threshold, and the five
clades were assigned different colors. Host disease
(UTI, UUI, SUI, OAB, bacteremia, and IE) of the
clinical strains are marked with colored dots. Host
disease information is unknown for strains
FDAARGOS_911 and ACS-120-V-Col10A. Strains
labelled UMB were isolated from urine collected by
transurethral catheterization. Other strains were
isolated from urine (U), blood (B) or heart valve (H).
Aerococcus urinae clade names were chosen based
on GTDB-tk calls. Red boxes denote strains used in
mouse experiments.
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this, examination of bladders collected 3 and 6 hpi by scanning
electronmicroscopy failed to detect adherentA. urinae bacteria on the
urothelial surface (Fig. 4B). The urothelium appeared intact, with no
signs of the exfoliation response initiated by other uropathogens
(Anderson et al., 2003; O’Brien et al., 2017; Gilbert et al., 2017).
Upon histological examination of formalin-fixed, paraffin-embedded
sections stained with Hematoxylin and Eosin (H&E), the appearance
of the transitional urothelium and superficial umbrella cells 4 hpi and
13 dpi was indistinguishable from that of PBS-inoculated control
mice (Fig. 4C). We also did not observe the robust infiltration of
neutrophils or edema in the bladder that are hallmark features of
UPEC chronic cystitis (Hannan et al., 2010). Like UMB80, the
additional A. urinae strains tested were not detectable in bladder
tissue in most mice (data not shown), and bladder histology was
indistinguishable from mice inoculated with PBS (Fig. S5). These
results point to a urinary tract source other than the bladder for the
persistentA. urinae bacteriuria observed in Fig. 2 and indicate that the
bladder is not be the primary niche for A. urinae during UTI.
Aerococcus urinae exhibits tropism for the kidney in
C3H/HeN mice
C3H/HeN mice exhibit vesicoureteral reflux, enabling bacteria
inoculated into the bladder to rapidly reach the kidney. Titers of
UMB80 were detected in the kidneys 4 hpi with an inoculum of 107
CFU, but not with 105 CFU. However, by 24 hpi, UMB80 was
detected at high levels in the kidneys, irrespective of inoculum dose
(Fig. 5A). This is consistent with the urine titer results that indicate
expansion of UMB80 in mice receiving a lower inoculum dose
(Fig. 2D). Kidney infection at early timepoints following
inoculation was a shared feature among the additional A. urinae
isolates tested (Fig. 5B). However, differences were observed
between strains at later time points. At 13 dpi, the presence of
detectable titers in kidneys reflected the persistent bacteriuria results
shown in Fig. 2; UMB3669 exhibited similar levels of kidney
infection as UMB80, whereas UMB722 and UMB5628 were not
detected in most kidney homogenates at this time point (Fig. 5B).
The rate of persistent kidney infection out to 13 dpi for each A.
urinae strain was: 90% (9/10) for UMB80, 20% (1/5) for UMB722,
80% (4/5) for UMB3669 and 0% (0/5) for UMB5628. In an
additional experiment, four of ten mice inoculated with 107 UMB80
had detectable titers in kidney tissue 34 dpi (Fig. 5B). Of particular
note, over half (7/12) of the mice that had detectable UMB80 titers
in kidney tissue did not have detectable bladder titers (Fig. 5C). In
mice with detectable UMB80 in both tissues, the titers in bladders
were significantly correlated with bacterial loads in the kidneys
(Fig. 5D). This result is consistent with the conclusion that A. urinae
Fig. 2. Acute and persistent bacteriuria displayed by
A. urinae strains. (A) Titers of each A. urinae strain in
urine collected 24 hpi. The clinical type of each isolate is
indicated across the bottom of the graph. *P<0.05 Mann–
Whitney test. (B–E) Time courses of bacteriuria caused
by UMB80 (B), UMB3669 (C), UMB722 (D) and
UMB5628 (E). Dotted lines on each graph denote the
limit of detection (1000 CFU/ml). The percentage of mice
with persistent bacteriuria out to 13 dpi is indicated on
each graph.
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detected in bladders at 13 dpi reflects bacteria descending from the
infected kidney. Together, these results demonstrate that some
strains of A. urinae can cause persistent kidney infection in C3H/
HeN mice independent of infection in the bladder.
To determine the spatial localization of UMB80 within the kidney,
we performed immunohistochemistry (IHC) with an antibody to
peptidoglycan, a component of the cell wall of Gram-positive
bacteria. This analysis revealed stained regions presumably
representing collections of A. urinae bacteria (Fig. 6; Fig. S6).
Positive staining was observed emanating from the collecting system
into the medulla and was in some mice detected in the cortex. The
signal was not contained within tubules, where UPEC has been
shown to localize during kidney infection (Olson et al., 2018), but
instead appeared to be in inter-tubular spaces. Since the primary
antibody detects a cell wall component, it is possible that some of the
staining detected free peptidoglycan released from the bacteria.
Importantly, positive signal was not present in kidney sections
collected from mice inoculated with PBS and stained in parallel.
Aerococcus urinae causes histological inflammation and
neutrophil recruitment to the kidney
In contrast to the bladders, the kidneys of mice inoculated with
UMB80 displayed histological inflammation 13 dpi (Fig. 7). The
degree of inflammation ranged from smaller collections to large
patches of inflammatory cells (Fig. 7A). Of note, some regions of
inflammation also showed positive staining with the anti-
peptidoglycan antibody, suggesting that the inflammation was
directed as sites of active infection (Fig. 7B). To determine the
identity of the immune cells infiltrating or expanding in the kidney,
we performed flow cytometry profiling of kidney tissue. This
analysis revealed a significant increase in neutrophils in the kidneys
of UMB80-infected mice compared to mock-infected controls
(Fig. 8A). We also profiled the levels of 23 cytokines in kidney
tissues at 24 hpi and 13 dpi (Fig. S7). Kidneys from UMB80
infected mice had significantly higher levels of IL-12p40 and
Eotaxin compared to control animals (Fig. 8B). While the source of
these cytokines remains to be determined, in the context of other
microbial infections, neutrophils have been shown to either produce
1L-12p40 themselves or induce production by other immune cells
such as DCs (Bliss et al., 2000; Bennouna et al., 2003). Eotaxin is
primarily produced by epithelial cells and endothelial cells.
Previous data showed that C3H/HeN mice with chronic UPEC
bacteriuria and kidney infection have abundant neutrophils in urine
(Hannan et al., 2010). However, we did not observe neutrophils
upon cytological analysis of urines collected 13 dpi from mice
infected with UMB80 or the other A. urinae isolates tested (data not
shown). Together, these data demonstrate that UMB80 preferentially
infects the kidney in C3H/HeN mice and triggers a neutrophilic
inflammatory response that remains contained within the tissue.
DISCUSSION
Aerococcus urinae is an emerging uropathogen that can cause
disseminated and potentially life-threatening infections, especially
in patients with predisposing risk factors such as urinary tract
abnormalities. While the pathogenic potential of different A. urinae
strains has been examined using genomic and in vitro phenotypic
data, infection outcomes have not previously been examined in vivo.
Here, we present a mouse model of A. urinae infection that enables
examination of tissue tropism and host immune responses. A. urinae
displayed a different course of infection in two genetically and
phenotypically distinct mouse strains. Consistent with A. urinae
infections being predominantly reported in patients with underlying
risk factors, including urinary tract abnormalities, A. urinae caused
more robust infection in mice with an inherent urinary tract
abnormality (VUR). As with any small animal model system, the
C3H/HeN mouse model has limitations, and it cannot be used to
understand all instances of A. urine UTI observed in humans. For
example, the absence of persistent bladder infection in mice by the
A. urinae limits the ability to study A. urinae-urothelial interactions
in vivo. Examination of additional A. urinae strains could identify
some more capable of infecting the bladder. It is important to note
here that it is not yet known whether A. urinae binds to the human
bladder urothelium during UTI. In addition to the expanded studies
mentioned below, the present model could be adapted to examine A.
urinae infection outcomes in the context of additional predisposing
factors, such as by adapting the established catheter-associated UTI
(CAUTI) mouse model (Guiton et al., 2010) in female mice.
Additionally, the model could be adapted to examine sex
differences in infection using established models of UTI in male
mice (Olson et al., 2016; Zychlinsky Scharff et al., 2017).
When comparing the results of this new A. urinae UTI mouse
model to the well-established uropathogenic E. coli (UPEC) UTI
model, there are some notable similarities and differences. Both
UPEC and A. urinae are more rapidly cleared and kidney infection
is rare in C57BL/6 compared to C3H/HeN mice (Hopkins et al.,
1998). C3H/HeN mice are more susceptible to prolonged (chronic)
bacteriuria and kidney infection because they have VUR, which
facilitates bacterial ascension from the bladder to the kidney (Bowen
et al., 2013). While persistent infection by both A. urinae and UPEC
occurs in C3H/HeN mice, there is a distinction with respect to tissue
tropism. C3H/HeN mice with chronic UPEC bacteriuria have high
bacterial burden both in bladder and kidney tissue (Hannan et al.,
2010), while A. urinae was undetectable in the bladder tissue of
many mice with kidney infection. Also in contrast to chronic UPEC
infection, mice with A. urinae infection and inflammation in kidney
Fig. 3. UMB80 bacteriuria in mice depends on inoculum dose. (A,B)
Comparison of acute bacteriuria caused by different UMB80 inoculum doses
in C3H/HeN mice at 3 hpi (A) and 24 hpi (B). Mann–Whitney test
***P<0.001, **P<0.01. (C,D) Time course of bacteriuria caused by the
indicated doses of UMB80 in C3H/HeN mice. All results are combined from
two independent experiments and each dot represents an individual mouse.
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tissue did not have pyuria and displayed no signs of distress
(lethargy, ruffled fur, hunched posture), suggesting that A. urinae
may be capable of causing a persistent but localized, kidney
infection. While it would be difficult to prove that A. urinae kidney
colonization in the absence of typical pyelonephritis symptoms also
occurs in humans, the possibility is consistent with the high
frequency at which A. urinae disseminates from the urinary tract
into the bloodstream to cause infection in other organs and tissues.
Initial mouse experiments included culturing of spleens and did not
detect disseminated A. urinae. Future studies could examine
whether dissemination in mice occurs given a longer timeframe,
or higher inoculum dose, or in immunocompromised mice.
Notable comparisons to other Gram-positive UTI models can be
made as well. Similar to A. urinae, transurethral inoculation of
Staphylococcus saprophyticus into C3H/HeN female mice
demonstrated higher bacterial titers in the kidney compared to the
bladder. Persistence of bacteria was noted in C3H/HeN mice but not
in C57BL/6 mice (Kline et al., 2010). Infection of Group B
Streptococcus (GBS) and Enterococcus faecalis under similar
conditions also demonstrated a kidney tropism (Kline et al., 2011;
Kau et al., 2005). This preference and persistence pattern of Gram-
positive uropathogens towards the kidneys over the bladder lends
itself to further investigation of UTI pathogenesis.
Outside of the context of a clinical UTI, two studies found A. urinae
more frequently present as part of the ‘urinary microbiome’ in women
with UUI (Pearce et al., 2014; Price et al., 2020). Of note, women with
UUI in these studies were older and more were estrogen negative than
women in the control group.Whether or not A. urinae colonization is a
cause or consequence of UUI, or is dependent upon age or hormone
status, remains to be determined. The results presented here from
bladder titers and microscopy do not provide any evidence for A.
urinae binding to the bladder urothelium in mice. This is perhaps not
surprising because A. urinae UTI would be expected to be more
common if it were capable of binding and invading superficial
urothelial cells in a similar fashion as professional uropathogens like
UPEC (Terlizzi et al., 2017). The observation thatA. urinaewas rapidly
cleared from the bladder in mice suggests that some perturbation of the
urothelium may be required to facilitate A. urinae in the bladder. It is
possible that women with UUI have an altered urothelium that
facilitates A. urinae bladder colonization, but so far bladder tissues
fromUUI patients have not been examined. Alternatively, the presence
of A. urinae in the urine of women with UUI could reflect infection of
the kidney. It is reasonable to speculate that if A. urinae kidney
infection and inflammation (without overt signs of pyelonephritis)
similar to what we observed in mice also occurs in humans, it could
result in lower urinary tract symptoms such as those associated with
Fig. 4. UMB80 is rapidly cleared from the bladder without apparent uroepithelial exfoliation or histological inflammation. (A) Titers of UMB80 in
bladder tissue homogenates collected at the indicated time points. Each dot represents an individual mouse. (B) Scanning electron microscopy image of the
luminal surface of a bladder from a mouse inoculated with UMB80, collected 6 hpi. Scale bar: 50 µm. (C) Formalin-fixed, paraffin-embedded bladder sections
stained with Hematoxylin and Eosin (H&E). Scale bars: 50 µm.
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UUI. Future studies could examine A. urinae infected mice for the
presence of incontinence, examine cytokines and chemokines in urine,
and could determine whether A. urinae bladder colonization is
enhanced in established mouse models of urinary incontinence (Jiang
and Damaser, 2011; Parsons and Drake, 2011).
Our ANI analysis is consistent with a previous study that did not
find a relationship between A. urinae phylogeny and disease status
(Carkaci et al., 2017). The 77 available A. urinae genomes separated
into five distinct clades, but none had an overrepresentation of
isolates from a particular disease state (e.g. UTI or bacteremia).
The lack of association with disease status suggests that all five
clades contain pathogenic strains. Since an ANI value of 95% is
typically considered the boundary for bacterial species (Jain et al.,
2018), our result suggests that A. urinae may consist of five closely
related species. Efforts are underway to test this hypothesis.
Likewise, while we observed differences in infection outcomes
between A. urinae isolates, these differences did not track with the
type of infection or lower urinary tract condition from which the
strain was isolated. We acknowledge the limitation that we
examined only a single strain from each clinical outcome and did
not examine a bacteremia isolate. Future studies with additional A.
urinae isolates are needed to establish whether UTI or bacteremia
isolates in general are more pathogenic. Taken together, our results
suggest that host factors, rather than bacterial ones, are a main driver
of A. urinae infections and are consistent with the concept that
A. urinae is primarily an opportunistic pathogen.
Previous studies have examined in vitro phenotypes that are
potentially important for pathogenesis. An analysis of five A. urinae
strains isolated from IE cases reported that plasma components could
stimulate platelet aggregation and biofilm formation (Shannon et al.,
2010). We recently reported self-aggregative properties of 24 A.
Fig. 6. Localization of A. urinae in kidney tissue kidney. Formalin-fixed,
paraffin-embedded kidney sections collected 13 dpi from mice inoculated
with either PBS or UMB80 and stained with primary antibody to the Gram-
positive cell wall component peptidoglycan. Scale bars: 100 µm.
Fig. 5. Aerococcus urinae causes acute and persistent kidney infection. (A) Titers of UMB80 in kidney homogenates collected at the indicated time
points following transurethral inoculation of the indicated doses in C3H/HeN females. (B) Titers of additional A. urinae strains in kidney homogenates
collected at the indicated time points. *P<0.05, **P<0.01, Mann–Whitney test. Rate of persistent kidney infection indicated under the 13 dpi titers.
(C) Correlation between kidney and bladder titers 13 dpi in mice receiving 107 CFU UMB80. (D) Kidney titer data from 106 CFU dose in panel A plotted
relative to the bladder titer data shown in Fig. 4A, demonstrating that kidney infection occurred independent from bladder infection. In all graphs, each dot
represents an individual mouse.
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urinae strains isolated primarily from postmenopausal women with
UUI or OAB (Hilt et al., 2020). A survey of the surface proteome of
A. urinae strains led to the characterization of two cell wall-anchored
proteins that are being studied for their adhesive properties (Senneby
et al., 2019). Future studies could examine the role of these, or other
phenotypes, for pathogenesis by comparing A. urinae strains in the
mouse model. Such efforts would be greatly enhanced by the
development of a genome-editing platform in A. urinae, similar to
those that have been successful with other Gram-positive
uropathogens (Keller et al., 2019; Penewit and Salipante, 2020).
We describe in this report a mouse model that offers to serve
for the study of bacterial and host factors in the pathogenesis
of A. urinae in the urinary tract. It will be especially useful for
studying A. urinae in the kidney, although future studies may also
reveal A. urinae strains capable of causing more persistent bladder
infection. Given how little is known about the mechanisms and
behaviors of infection, this model should aid in understanding the
role of A. urinae in urinary tract diseases.
MATERIALS AND METHODS
Genome analysis: read quality control, contigs assembly and
genome quality assessment
All publicly available raw reads for A. urinae whole genome sequencing
projects were downloaded from SRA (https://www.ncbi.nlm.nih.gov/
genome/browse/#!/prokaryotes/3029/) and ENA (https://www.ebi.ac.uk/
ena/browser/view/PRJEB36767). The quality of the raw reads was
assessed using FastQC (https://www.bioinformatics.babraham.ac.uk/
projects/fastqc/) and trimmed using bbduk (https://jgi.doe.gov/data-and-
Fig. 7. UMB80 triggers histological inflammation in the kidney. (A) Formalin-fixed, paraffin-embedded kidneys collected 13 dpi from mice transurethrally
inoculated with PBS or UMB80 were sectioned and stained with H&E. Scale bars: 200 µm. (B) Adjacent kidney sections from a mouse inoculated with
UMB80 stained with H&E or with an antibody to peptidoglycan. Scale bars: 20 µm.
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tools/bbtools/). Bases with low quality scores (qtrim=rl, trimq=10) and
positions with high compositional bias (ftl=15, ftr=135 or 239 depending on
the samples) were removed from both ends. Only reads with minimum read
lengths of 30 bp (minlength=30), with no Ns (maxns=0), and with an
average quality above 10 (maq=10) were kept. After quality control, all of
the clean paired-end reads were assembled using SPAdes (v3.14.1)
(Bankevich et al., 2012) with the (–isolate) mode. The full k-mer size list
(-k 21, 33, 55, 77, 99, 127) or (-k 21,33,55,77) was used in the assembly
depending on the sequence length of samples. CheckM (v1.0.12) (Parks
et al., 2015) was then used to assess completeness and contamination of the
assembled genomes using the ‘lineage_wf’ pipeline, and genomes were
filtered at completeness ≥90% and contamination ≤5% to obtain high-
quality genomes. Samples with contamination above 5% were then filtered
usingMaxBin 2.0 (v2.2.7) (Wu et al., 2016) to recover high-quality genome
bins. dRep (v2.2.3) (Olm et al., 2017) was used to compare the average
nucleotide identity (ANI). 95% ANI values calculated by fastANI (Jain
et al., 2018) were used to cluster genomes into different groups (-sa 0.95
–S_algorithm fastANI –SkipMash). An ANOVA was performed
considering ANI values by clade and symptom group using R (v4.0.5).
Ethics statement
Mouse experiments were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals. The Institutional Animal Care and Use Committee (IACUC) of
Washington University School of Medicine approved the protocols
(Protocol Number: 20170081 and 20-0031).
Mice
Six- to seven-week-old female C57BL/6 mice were obtained from Charles
River (Fredericks facility), and C3H/HeN mice were obtained from Envigo
International Holdings. Mice were given a regular chow diet in a specific
pathogen-free facility at Washington University School of Medicine.
Bacterial strains and growth conditions
Aerococcus urinae strains UMB80, UMB722, and UMB3669 were
compared side-by-side in three independent mouse experiments and an
additional experiment compared UMB80 and UMB5627. The strains were
first streaked from frozen stocks onto BHI agar plates and grown in 5% CO2
atmospheric conditions at 37°C for 48 h. These plates were used to start
10 ml liquid BHI cultures incubated statically under the same conditions
overnight (∼18 h). Prior to performing mouse experiments, we empirically
determined the appropriate OD600 equivalent required to achieve an ∼107
CFU (as determined by serial dilution plating) dose in 50 µl PBS for each
strain. We found that UMB80 needed to be concentrated to an OD600 of 10
and UMB722 needed to be concentrated to an OD600 of 5. Because of the
aggregation of UMB3669, we did not rely on OD determination, but found
that we could achieve the desired inoculum dose when resuspending the
culture pellet in the same volume of PBS that was determined for UMB722.
For mouse experiments, the overnight cultures were centrifuged and
the bacterial pellets were re-suspended in sterile PBS. The inocula were
serially diluted and plated on BHI media to confirm that the target CFU
dose was achieved. Of note, trituration of UMB3669 in PBS facilitated
dispersal of large aggregates and achieved a homogenous and suspended
inoculum.
A streptomycin-resistant strain of Gardnerella vaginalis JCP8151B was
streaked from frozen stock on NYCIII agar plates and grown at 37°C for
∼24 h in a Coy anaerobic chamber. These plates were used to start 3 ml
NYCIII static liquid anaerobic cultures incubated at 37°C overnight for
∼18 h.G. vaginalis inoculum was prepared in PBS at OD 5 (∼5×107–1×108
CFU in 50 μl).
Mouse urinary tract inoculation experiments
Mice were anesthetized with isoflurane and then inoculated transurethrally
with 50 μl prepared inocula as previously described (Kline et al., 2012,
2014). Urine was collected from mice and monitored for A. urinae titers by
dilution plating on BHI supplemented with 50 μg/ml kanamycin. This
selective plating strategy takes advantage of the natural kanamycin
resistance of these four A. urinae strains (not shown) and was necessary
because ‘clean catch’ urine is not possible from a mouse; resident urogenital
microbiota inevitably grow on non-selective BHI media and preclude
enumeration of A. urinae. At the experimental endpoint, mice were
humanely sacrificed (cervical dislocation under anesthesia), and bladders
and kidneys were aseptically harvested, kept on ice, and homogenized in
PBS for serial dilution and plating to enumerate A. urinae titers on BHI+kan
media. Initial experiments also collected spleens, but disseminatedA. urinae
were not detected. Remaining homogenates were centrifuged 13,000 rpm
in a benchtop microcentrifuge for 5 min at 4°C to remove debris and
supernatants were stored at −20°C for cytokine analysis.
Growth curves
Growth curves of A. urinae strains were measured by optical density at
600 nm with an Epoch 2 microplate reader (BioTek Instruments Inc.). The
strains were first streaked from frozen stocks onto BHI agar plates and grown
in 5% CO2 atmospheric conditions at 37°C for 48 h. Strains were then
inoculated into 5 ml liquid BHI medium in a six-well plate (Corning, Inc.)
and read with shaking at 200 rpm for 48 h kept at 5% CO2 atmospheric
conditions. An additional read was conducted with the same strains
passaged 1:10 into fresh media for another 48 h.
Fig. 8. Neutrophils (PMNs) and pro-inflammatory cytokines are
increased by UMB80 in the kidney. (A) Flow cytometry of immune cells in
kidneys from mice inoculated with PBS (open symbols) or UMB80 (closed
symbols), collected 13 dpi. One-way ANOVA followed by Šıd́ák’s multiple
comparisons tests; ****P<0.0001; *P<0.05. (B) Cytokine levels in kidney
homogenate supernatants collected at the indicated time points. One-way
ANOVA followed by Dunnett’s multiple comparisons tests; ***P<0.001; n.s.,
not significant.
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For ultrastructural analyses, A. urinae cells prepared in PBS (as for mouse
inoculations) were spun at 500 rpm; pellets were fixed in 2%
paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington,
PA, USA) in 100 mM sodium cacodylate buffer, pH 7.2 for 1 h at room
temperature. Samples were washed in sodium cacodylate buffer at room
temperature and postfixed in 1% osmium tetroxide (Polysciences Inc.) for
1 h. Samples were then rinsed extensively in dH2O prior to en bloc staining
with 1% aqueous uranyl acetate (Ted Pella Inc., Redding, CA, USA) for 1 h.
Following several rinses in dH2O, samples were dehydrated in a graded
series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.).
Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome
(Leica Microsystems Inc., Bannockburn, IL, USA), stained with uranyl
acetate and lead citrate, and viewed on a JEOL 1200 EX transmission
electron microscope (JEOL USA Inc., Peabody, MA, USA) equipped
with an AMT 8-megapixel digital camera and AMT Image Capture
Engine V602 software (Advanced Microscopy Techniques, Woburn, MA,
USA).
Scanning electron microscopy
Bladders were fixed in situ as previously described (O’Brien et al., 2020)
with EM fixative (2% paraformaldehyde, 2% glutaraldehyde in 0.1 M
sodium phosphate buffer, pH 7.4). Samples were prepared by critical point
drying. Briefly, samples were post-fixed in 1.0% osmium tetroxide,
dehydrated in increasing concentrations of ethanol, and then dehydrated at
31.1°C and 1072 PSI for 16 min in a critical point dryer. Samples were
mounted on carbon tape-coated stubs and sputter-coated with gold/
palladium under argon. Bladders were imaged on a Zeiss Crossbeam 540
FIB-SEM.
IHC analysis
Formalin-fixed, paraffin embedded bladders and kidneys were sectioned
and stained with H&E by the histology core in the Department of Obstetrics
and Gynecology at Washington University School of Medicine (St. Louis,
MO, USA) or by Nationwide Histology (Missoula, MT, USA). For IHC,
slides were deparaffinized in xylene followed by a graded series of ethanol
washes. Slides were rehydrated in running water and antigen retrieval was
performed by microwaving for 20 min in sodium citrate buffer, pH 6 with
0.05%Tween 20. Slides were blocked for 1 h with 1%BSA+0.3%Triton X-
100 in PBS, probed for 1 h with a 1:150 dilution of monoclonal anti-
peptidoglycan antibody (Invitrogen #MA5-16509) in same buffer, washed
with PBS, and probed for 30 min with 1:200 dilution of biotinylated
secondary antibody. Signal was detected using Vectastain Elite ABC
reagent and DAB solution.
Urine cytology
Eighty microliters of a tenfold dilution of urine was cytospun onto coated
CytoPro Dual microscope slides and stained with a Hema 3 staining kit
(Thermo Fisher Scientific) to visualize epithelial cells and neutrophils
(PMNs). Slides were observed on an Olympus Vanox AHBT3 microscope
Flow cytometry
Kidneys were harvested after terminal perfusion with PBS into cold RPMI.
Manual dissociation was used to create a single-cell suspension. Cells were
then treated with RBC lysis buffer (155 mM NH4Cl, 10 mM KHCO3) at
room temperature to remove any remaining red blood cells. After washing,
cells were subjected to a Percoll gradient (Percoll Plus; GE Healthcare,
Uppsala, Sweden) in FACS buffer [10% FBS, 1% w/v sodium azide, 2 mM
ethylenediaminetetraacetic acid (EDTA) in PBS]+25 mM sucrose for
leukocyte enrichment, then resuspended in cold PBS and stained with
Live/Dead Fixable Blue (Thermo Fisher Scientific). Following another
wash, cells were blocked with CD16/CD32 antibody (BD Biosciences,
San Jose, CA, USA) on ice and stained with fluorescently conjugated
antibodies against the following extracellular antigens: MHC-II-BUV395
(BD Biosciences #BDB743876), CD115-BV480 (BD Biosciences
#BDB746456), CD45-BV510 (BD Biosciences #563891), CD11b-
BV570 (BioLegend #101233), Ly6C-BV605, CD19-Qdot655 (Invitrogen
#501138153), CD11c-BV785 (BioLegend #117336), CD3-SparkBlue550
(BioLegend #100260), F4/80-BB700 (BD Biosciences #BDB746070),
TCRγδ-PE-Cy5 (BioLegend), CD4-APC (BD Biosciences #553051),
Ly6G-AlexaFluor 700 (BioLegend #127621), and CD8a APC-Cy7 (BD
Biosciences #557654). Cells were washed, resuspended in FACS buffer
and analyzed on an Aurora flow cytometer (Cytek Biosciences). Analysis
was performed using the FlowJo software (BDBiosciences). Gating strategy
used to determine immune cell types is illustrated in Fig. S8.
Bioplex cytokine analysis
Tissue homogenate supernatants collected as described above were thawed
on ice, centrifuged again at 4°C to remove any remaining particulates.
Cytokine content was measured using the Bio-Plex-Pro Mouse Cytokine
23-Plex Panel multiplex cytokine bead kit (Bio-Rad), which quantifies 23
different cytokines and chemokines. The assay was performed according to
manufacturer instructions, except using tenfold less standard and half the
amount of coupled beads and detection antibodies indicated in the protocol.
Statistics
The figures show individual data points for each animal with a line at the
geometric mean or with box and whiskers (min. to max.) plots. The
statistical tests used to analyze each set of data, as indicated in the figure
legends, were determined using Prism 9 (GraphPad) software. For analysis
of cytokines, raw uncorrected P-values are provided.
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